|
such as amitriptyline and nortriptyline. Current
medicines are known as "selective reuptake
inhibitors", a listing of these drugs is found
in the lower left column of this web page.
Comprehensive review of the scientific
literature reveals the prescription drugs
used to treat depression achieve relief of
symptoms better than a sugar pill (placebo) in
only 7% of all patients treated. Most notable is the
"placebo effect" in depression studies which
reveals that 30% to 40% of patients taking a
sugar pill (placebo) achieve relief of symptoms.
This leads to confusion in the clinic with
doctors. A doctor treats a group of patients
with drugs then 50% get better in the first
month, the doctor attributes all of these
outcomes to the drug when in fact most of the
patients getting better would have gotten better
without any drugs (placebo effect).
Depression Elderly
Drugs In
the Elderly
Treatment of depression studies with drugs in the
elderly (patients 65 years old and older) reveals that
the commonly used depression drugs are no better than a sugar pill. Elderly patients
get no relief of symptoms of depression when treated
with prescription drugs. No elderly patient should be
prescribed drugs for treatment of depression. The fact
is prescribing drugs for depression to the elderly does
much more harm than good.
Depression Elderly
The Bottom Line
In
treating any patient with a prescription drug for
depression the odds of developing a drug side effect are
higher than getting relief of symptoms that is greater
than a sugar pill. Add to this the fact that reuptake
inhibitor drugs deplete neurotransmitters (serotonin and
dopamine) making the cause of the problem worse while
trying to treat the symptoms these drugs are of
questionable value in clinics. The only way to prevent
depletion of serotonin and dopamine by these drugs in
treatment is to give balanced nutrients (5-HTP,
tyrosine, levodopa, and cysteine) with their administration.
Depression Elderly
Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa,
and cysteine to treat medical
patients in order to get these
results. Proper
use of these simple ingredients in
medical treatment is not simple.
From time to time a patient will
say, "Why do I want to take that, I
can go to a health food store and
buy it?" People off the street
buying in a health food store is
like going to an art store and
buying a bunch of oil paints then
going home and expecting to paint
like a mater artist even though
there was no previous painting
experience. These nutrients have
tremendous potential due to their
chemical properties. This potential
is only fully realized in the hands
of the trained professional using
neurotransmitter testing. Treatment
is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control.
The Peer Reviewed Research
of NeuroResearch Clinics
The neurotransmitter treatment research findings of NeuroResearch Clinics
have not been ignored. The University of
Minnesota Medical School is writing a series of
papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid
Kohlstadt, MD of Johns Hopkins in her new
medical text book released February 7, 2009
included a chapter on depression written by
Marty L. Hinz, MD President Clinical
Research NeuroResearch Clinics outlining in
depth the proper use of amino acids and
neurotransmitter testing in treatment of
depression.
|
